The demographic argument for healthcare commercial real estate has been one of the most reliable analytical frameworks in the investment world for the better part of fifteen years. The math was never complicated: Americans are aging at a pace without historical precedent, older people consume vastly more healthcare services than younger ones, and healthcare services require physical space. Buy medical office buildings, hold them through the cycle, collect the rent from tenants whose demand is driven by biology rather than economic sentiment, and outperform. The thesis worked because it was structurally sound.
It is still structurally sound. But it is no longer the complete picture, and investors who treat it as though it is will systematically underperform the investors who understand what has changed.
Artificial intelligence is not coming to healthcare real estate as a future consideration to be monitored and revisited. It is already here, already operating inside medical facilities, and already changing the fundamental economics of how healthcare space is used, what it earns, and which assets are positioned to capture the next decade of value creation. The demographic story gave investors the demand. AI is now changing the supply — not the supply of buildings, but the supply of productive capacity inside them. That distinction is consequential in ways that the current market commentary has almost entirely failed to engage with.
The sector’s fundamentals heading into 2026 are among the strongest in the history of healthcare commercial real estate. Medical office occupancy nationally closed at approximately 93 percent — the highest level in a decade, with many submarkets running above 95 percent. New construction delivered in 2026 is tracking at the lowest annual volume in more than a decade, down roughly 26 percent from already-constrained prior years. Triple-net MOB rents have increased 8.8 percent over three years, averaging 2.4 percent annually in an asset class not historically known for rent growth. Investment volume reached $14 billion in 2025, up 34 percent year-over-year, with portfolio transactions accounting for approximately $7 billion of that total. Cap rates compressed 20 to 40 basis points in the back half of 2025. Ten-year total returns for MOB have run at 6 percent annually versus the NCREIF index at 4.9 percent.
None of those numbers are speculative. They are the documented current state of an asset class that has been quietly outperforming while the rest of the CRE market absorbed a cycle of rate-driven repricing. The question for investors in 2026 is not whether healthcare real estate is a good place to be. It demonstrably is. The question is which healthcare real estate, and why, and what structural forces are going to determine which assets compound and which ones stagnate. Demographics will tell you the sector. AI will increasingly tell you the asset.
This piece sits at the intersection of Asset Classes, Market Analytics, and Underwriting — and draws on the same analytical lens BestCRE has applied across the 20 CRE sectors it covers.
What a Decade of Demographics Actually Built
To understand why AI represents a qualitative shift in the healthcare CRE thesis, it helps to be precise about what the demographic argument actually established. The United States population aged 65 and older grew 3.1 percent between 2023 and 2024 — during the same period, the population under 18 declined 0.2 percent. The cohort aged 75 and older is now growing at more than one million people per year, a rate roughly triple the historical average. National healthcare spending is approaching two trillion dollars annually. Healthcare sector employment has been expanding at 2.8 percent per year, consistently outpacing total nonfarm payroll growth.
These are not marginal trends. They are tectonic demographic shifts that have been underway for years and have longer to run. The oldest Baby Boomers turned 80 in 2026. The cohort behind them is larger. The demand for healthcare services — and by extension for the physical space in which those services are delivered — was always going to intensify regardless of economic conditions, regardless of interest rates, and regardless of policy. That structural immunity to economic cyclicality is the core reason institutional capital has consistently found healthcare real estate attractive relative to other CRE asset classes.
But the demographic argument, taken in isolation, answers only one question: will there be demand? It says nothing about how efficiently that demand will be served, how much space will be required to serve it, what that space will need to do, or which operators and properties are positioned to capture the economics of rising utilization. Those questions — the ones that actually determine asset-level performance — are increasingly being answered by artificial intelligence, not by age cohort projections.
The Outpatient Migration: The Structural Shift That Changed the Real Estate
Before arriving at AI specifically, the healthcare real estate story requires a full accounting of the structural shift that has already fundamentally reshaped the asset class: the migration of clinical care from inpatient hospitals to outpatient ambulatory settings. This shift is the precondition for understanding what AI is doing to the space, because the space itself has already changed dramatically.
Outpatient revenue has grown 45 percent since 2020. Inpatient revenue grew 16 percent over the same period. That is not a rounding difference — it is a structural reorientation of how healthcare is delivered and where the economics are accreting. Projections point to 10.6 percent additional outpatient revenue growth over the next five years. Outpatient spine procedures — the kind of complex, high-acuity work that was definitionally hospital-based a decade ago — have increased 193 percent over the last ten years. Cardiology, spinal surgery, and other previously hospital-anchored specialties are migrating to ambulatory surgery centers and medical office buildings at an accelerating rate.
The policy environment has reinforced this shift. The legislation commonly referenced as the “One Big Beautiful Bill,” enacted in July 2025, embedded approximately one trillion dollars in Medicaid cuts over ten years and is projected by independent analysts to result in 14.2 million Americans losing insurance coverage. The direct consequence of reducing covered lives is intensified pressure on providers to reduce per-episode costs — which means steering more care to lower-cost outpatient settings, accelerating a migration that was already underway on clinical grounds. Healthcare policy, in other words, is now aligned with clinical trends in pushing care out of hospitals and into ambulatory real estate.
The real estate implications of this shift are significant and have been extensively documented: demand for well-located, purpose-built outpatient medical office space is rising, hospital systems are acquiring and occupying more off-campus ambulatory space, and the medical office building — which was once considered a somewhat specialized niche within the broader office category — has established itself as a genuinely distinct institutional asset class with its own demand drivers, its own tenant credit profiles, and its own fundamental trajectories.
That is the context into which AI is arriving. The outpatient migration already created the asset class. AI is now beginning to determine which assets within that class will create the most value.
Why AI Is the New Demographic
The framing of “AI as the new demographic” is deliberately provocative, and it is worth being precise about what it claims and what it does not. It does not claim that demographics no longer matter. The aging of America is a real, ongoing, and powerful demand driver that will continue operating for decades. The claim is narrower and more specific: that AI has emerged as an independent structural force that changes the economics of healthcare real estate from the inside — not by generating more patients, but by changing what happens to those patients once they arrive, how efficiently the space that serves them operates, and consequently how much that space is worth.
Demographics expand the demand pool. AI expands the productive capacity of the space serving that demand. When AI increases the effective output of a medical facility without requiring more square footage, it is doing something the demographic argument never contemplated: it is changing the revenue-generating potential of existing space. That has direct implications for underwriting, for cap rates, for rent growth, and for the bifurcation between assets that are positioned to capture AI-driven productivity gains and assets that are not.
The mechanism is straightforward even if the implications are not yet fully priced into the market. The FDA has cleared more than 1,000 AI tools for clinical use. Ambient scribing technology — AI that listens to patient-physician conversations and automatically generates clinical documentation — is the first digital health intervention in twenty years demonstrating measurable, statistically significant reductions in physician burnout. AI-driven documentation tools are reducing the time physicians spend on after-hours EHR entry and increasing the time they spend in face-to-face patient interaction. Revenue cycle automation is accelerating payment timelines and reducing denial rates. Prior authorization tools are compressing the administrative friction that has historically been one of the most significant operational costs in ambulatory care settings.
None of those are theoretical benefits awaiting future deployment. They are operational realities at scale in functioning ambulatory facilities, and they are changing what a medical office building can earn per square foot.
The Space Economics Are Already Shifting
The most underappreciated dimension of AI’s impact on healthcare real estate is quantitative, and the numbers are not speculative — they are being documented in operating facilities.
AI-driven exam room utilization optimization — deploying real-time occupancy sensing, predictive scheduling algorithms, and patient flow modeling — is increasing exam room utilization rates by up to 20 percent in early-adopting facilities. That figure matters to a real estate investor for a specific reason: it means that a practice operating in a given square footage can serve meaningfully more patients without moving to a larger space. The demand that demographics creates is being absorbed more efficiently. If a medical group was planning to lease an additional 3,000 square feet to handle increasing patient volume, and AI-driven utilization improvements allow them to absorb that volume in their existing footprint, that is 3,000 square feet of demand that does not materialize — in that location, from that tenant.
The revenue side of the equation is equally compelling. Research quantifying AI-assisted practice optimization places the annual revenue increase per exam room at up to $34,000. To put that in context: a typical primary care practice might operate eight to twelve exam rooms. Even at conservative AI adoption levels, the per-room revenue improvement is material relative to the cost of lease obligations. McKinsey’s research on AI implementation across real estate sectors puts net operating income improvement from AI-driven efficiency at greater than ten percent.
The Kontakt.io AI agent suite, demonstrated at the ViVE 2026 healthcare technology conference, provides some of the most specific operational data available. Its Patient Journey Analytics agent, Supply Chain agent, Access agent, and Patient Flow agent collectively produced the following documented results in a 200-bed hospital implementation: equipment search time reduced by 89 percent, medical device rental costs reduced by 76 percent, and equipment utilization increased by 1.8 times. Those are not efficiency improvements at the margin. They represent fundamental changes in how clinical operations interact with physical space — which assets they need, how much of them, and how they are configured.
The implications for real estate underwriting are layered. In the near term, AI is improving the operating performance of tenants in existing space, which improves their ability to pay rent and reduces default risk — a credit quality improvement that should, in theory, influence cap rates. Over the medium term, as AI-driven utilization optimization becomes widespread, the facilities purpose-designed to support AI-assisted care delivery will separate from legacy medical office stock that was not built with those operational requirements in mind. That is the bifurcation — the same structural dynamic that BestCRE has documented in the office market between trophy and legacy product and in the industrial market between power-ready and conventional warehouse.
How AI Is Physically Redesigning Healthcare Space
The bifurcation between AI-optimized and legacy medical office product is not primarily a technology story — it is a real estate story about physical design, infrastructure, and the spatial requirements of AI-assisted care delivery. Understanding those requirements is essential for investors evaluating which assets are positioned for the next cycle.
Firms including Gensler have been deploying AI modeling tools to optimize the physical design of healthcare facilities: room adjacencies, waiting area capacity, staff circulation patterns, and treatment room configurations are being tested against patient flow models and utilization projections before a single wall is framed. The result is facilities where the physical layout is derived from operational data rather than architectural convention — designs that reduce staff walking distance, minimize patient wait time through intelligent spatial sequencing, and configure exam and procedure rooms for the specific clinical workflows the tenant is running. The design difference between a building optimized this way and a legacy medical office building from fifteen years ago is not visible in a photograph. It is visible in the utilization data, the patient throughput numbers, and the revenue per square foot.
Staff circulation pattern mapping using AI is demonstrating measurable reductions in clinical staff fatigue and improvement in care delivery efficiency — both of which have direct implications for real estate. When a facility is designed to minimize unnecessary movement, it requires different dimensions, different corridor widths, different adjacency relationships between procedure rooms and support spaces. Retrofitting a legacy building to meet those requirements is expensive and often physically impossible without structural modifications. A purpose-designed AI-ready facility simply operates differently from day one.
Generative design tools — AI systems that produce multiple optimized layout configurations from a set of operational constraints — are being used by healthcare architects and health systems to compare dozens of floor plan variants against patient flow projections, regulatory requirements, and operational efficiency metrics before ground is broken. The comparison is then not between “what the architect designed” and “what the tenant requested” but between a range of data-optimized configurations evaluated against the specific clinical program the tenant intends to run. Buildings emerging from that process have a different relationship to their tenants’ operational requirements than buildings designed by conventional means.
Smart building infrastructure is the physical substrate that makes AI-driven facility management possible at the asset level. Real-time HVAC optimization based on occupancy sensing and weather data, predictive maintenance systems that flag equipment issues before they cause clinical downtime, lighting and energy systems that respond to room-by-room occupancy in real time — these capabilities require building infrastructure investments that legacy medical office stock does not have and cannot easily be retrofitted with. The difference is analogous to the electrical specification premium that BestCRE documented in the industrial sector: the asset that can support what the tenant actually needs to do is not the same asset as the one that was built for a different operational era, even if both are listed under the same property type in a database.
The Welltower Signal: What Institutional Capital Is Telling the Market
The single most consequential transaction in the history of healthcare commercial real estate closed in 2025, and it has not received the analytical treatment it deserves. Welltower’s disposition of a 296-asset, 18-million-square-foot portfolio — including outpatient medical facilities across 34 states — to a consortium involving Remedy Medical Properties and Kayne Anderson Real Estate, at a transaction value of approximately $7.2 billion, was not simply a large deal. It was an institutional repositioning signal of the first order.
Welltower, as one of the largest healthcare REITs in the world, was managing a balance sheet and making allocation decisions with information sets that few private investors can match. The portfolio sale was accompanied by explicit strategic commentary about repositioning capital toward senior housing and other care models aligned with demographic acceleration. The buyers — Remedy and Kayne Anderson — were making the equally explicit bet that high-quality outpatient medical assets at scale represent a durable, long-duration income play with defensible occupancy and rent growth.
Both sides of that transaction were right in different ways, and the tension between them is instructive. Welltower’s thesis is that senior housing is where the demographic and AI convergence is most powerful — the acceleration of care for the oldest and most medically complex patients, optimized by AI, in settings purpose-designed for that population. Remedy and Kayne Anderson’s thesis is that quality outpatient medical office at institutional scale offers a core income profile that justifies the acquisition basis even in a compressed cap rate environment. The $7.2 billion transaction is evidence that both theses attracted sophisticated capital simultaneously — which is a reasonable definition of a market in the early stages of bifurcating around a new value-creation thesis.
The transaction also signaled something important about portfolio scale and operational intelligence. At 296 assets and 18 million square feet, the buyers acquired not just physical real estate but a platform — a dataset of occupancy, utilization, tenant credit, and market dynamics that, when analyzed with AI-powered tools, becomes a source of underwriting advantage for future capital allocation. The institutions running the largest healthcare real estate portfolios are not just collecting rent; they are building proprietary data assets that compound in value as AI systems become more capable of extracting insight from them.
The Supply Constraint Is Structural, Not Cyclical
The demand side of the healthcare CRE thesis is well understood. The supply side is underappreciated, and the supply constraint is one of the most important structural supports for MOB fundamentals over the next several years.
New medical office construction has been declining for years and is now at its lowest annual delivery volume in more than a decade — down approximately 26 percent in 2026 from an already-constrained prior period. This is not a cyclical construction pause driven by capital costs, though elevated rates have certainly contributed. It reflects structural barriers to MOB development that are more durable than any single interest rate environment: the entitlement complexity of medical facilities (zoning, environmental, and healthcare licensing requirements that add time and cost to the development process), the long lead times required for health system credit tenants to commit to new locations, and the physical and infrastructure requirements of purpose-built medical space that make cost-effective development dependent on market conditions that have become rarer.
The result is a supply-demand imbalance that is not going to resolve quickly. MOB occupancy at 93 percent nationally means that functional availability in most markets is in single digits. In markets with above-average demographic pressure — Sun Belt metros, high-growth suburban nodes, markets with large and growing Medicare-age populations — availability is even tighter. The pipeline capable of alleviating that tightness is not there, and in the timeframe that matters for a current acquisition decision, it will not be built fast enough to prevent continued rent growth in well-located, high-quality assets.
The adaptive reuse trend — vacant retail and office space being converted to medical use — is a legitimate partial offset, but it is not a solution to the fundamental supply problem. Retail-to-medical conversions have produced a meaningful number of functional healthcare facilities, particularly for urgent care, imaging, and other clinical uses that do not require surgical infrastructure. But the universe of retail and office space that can be economically and functionally converted to meet the requirements of a health system’s ambulatory care program is limited. The assets most in demand — surgery center-ready space, multi-specialty campuses, oncology and cardiology facilities with the infrastructure those specialties require — cannot be produced by retrofitting a former big-box store.
Who Is Investing in Healthcare Real Estate — and How to Access It
The capital composition of the healthcare commercial real estate market has shifted materially over the past two years, and understanding who is buying and why matters for investors trying to assess entry points and competitive dynamics.
The dominant institutional buyers are REITs — Welltower, Healthpeak Properties, and Physicians Realty Trust among the largest — along with dedicated healthcare real estate private equity platforms, major pension funds, sovereign wealth funds investing through domestic fund structures, and the health systems themselves, which have become significant real estate owners as they pursue ambulatory network expansion strategies. Public REITs have been net sellers at the portfolio level in recent periods, focused on balance sheet management and capital recycling. That selling has created acquisition opportunities for private capital, which has moved aggressively into the space. The $7.2 billion Welltower transaction is the most visible expression of this dynamic, but similar rotations have been occurring across the market at smaller scales.
Private equity healthcare real estate funds have expanded significantly, raising capital from institutional limited partners — endowments, foundations, family offices, pension systems — and deploying it into acquisition, development, and value-add strategies across MOBs, ambulatory surgery centers, senior housing, and behavioral health facilities. The fund structures provide diversification across markets and asset types that individual investors cannot replicate through direct ownership of a single asset.
For family offices and accredited individual investors, the access question has historically been complicated. Direct ownership of a healthcare real estate asset — a medical office building, a surgical center — requires capital, operational expertise, and market relationships that most non-institutional investors do not have independently. The most practical path to healthcare real estate exposure for this investor profile is through private equity fund structures that allow smaller capital commitments alongside institutional investors, providing access to institutional-quality deal flow, underwriting discipline, and portfolio diversification. Several private fund platforms have emerged specifically to serve this segment, offering both direct ownership structures and fund vehicles oriented toward the accredited investor market. The risk-return profile, hold period, and liquidity terms vary meaningfully across these structures, and diligence on the operator and the specific asset strategy matters more than in any headline market condition.
The democratization of institutional-quality healthcare real estate investment is a real trend, and it reflects the broader recognition that MOBs and ambulatory facilities offer the kind of durable, inflation-resistant income that family offices and high-net-worth investors have traditionally sought in other asset classes. The entry points matter — and the analytical framework for distinguishing AI-positioned assets from legacy medical office stock is the new due diligence variable that will separate the next generation of outperformers from the ones that merely track the demographic tailwind.
The Bifurcation Is Beginning: AI-Ready Versus Legacy Medical Office
The bifurcation between AI-optimized healthcare facilities and legacy medical office stock is not yet fully expressed in transaction pricing or cap rate differentials. That lag is characteristic of structural bifurcations in commercial real estate — the office market’s trophy-versus-commodity split was visible in utilization data and tenant demand well before it was legible in investment sales comparables. The industrial market’s electrical specification premium was identifiable in lease economics and tenant requirements before the acquisition market repriced to reflect it. Healthcare real estate is in the early stage of the same pattern.
The leading indicators are already visible to investors willing to look. In markets with strong AI adoption among medical tenants — health systems that have deployed ambient scribing at scale, multi-specialty groups running AI-powered scheduling and patient flow optimization, surgical centers using predictive demand modeling — the space requirements conversation has changed. Tenants are asking different questions about buildings: not just how many exam rooms and what is the parking ratio, but what is the building’s sensor infrastructure, how is HVAC controlled, what is the data connectivity specification, does the mechanical system support the predictive maintenance platform we are deploying. Those questions are being asked more frequently, and the buildings that cannot answer them satisfactorily are losing competitive positioning with the most operationally sophisticated tenants.
The rent growth trajectory supports the bifurcation thesis. Triple-net MOB rents up 8.8 percent over three years represents an above-inflation pace for a traditionally stable asset class. But the aggregate figure obscures the distribution. Assets with health system credit tenants, strong location fundamentals, and modern infrastructure are achieving rent growth at the upper end of that range and beyond. Assets with independent physician group tenants in older buildings with deferred capital expenditure are growing more slowly and facing higher tenant improvement demands at renewal. The spread between those two cohorts is the early expression of the bifurcation, and it will widen as AI-driven operational differences become more apparent in tenant financial performance.
The parallel to the data center market’s redefinition of location is worth drawing explicitly. In data centers, as BestCRE has documented, power access became the new location variable — a facility in a remote geography with reliable, low-cost power access outperformed a facility in a prime geography with constrained power infrastructure. In healthcare real estate, AI readiness is becoming the new location variable — not replacing the importance of physical location, patient catchment, and access, but adding a new dimension along which assets differentiate. The facility that can support AI-assisted care delivery at full operational maturity is not the same asset class as the facility that cannot, even if both sit in the same submarket with comparable demographics.
The Compound Effect: Demographics Times AI
The most important analytical point about AI in healthcare real estate is that it does not replace the demographic argument — it multiplies it. Demographics create a rising volume of patients requiring care. AI expands the productive capacity of the facilities serving those patients while simultaneously improving the economics of care delivery. The compound effect is a healthcare real estate market where the underlying demand driver (aging population) is running at full acceleration while the operating efficiency of the physical assets serving that demand is improving in real time.
The investment thesis that captured this compound effect early — health systems acquiring ambulatory networks designed for AI-assisted care delivery, private equity platforms building portfolios of purpose-built outpatient facilities with modern infrastructure, institutional investors funding development of AI-ready medical campuses near high-demographic-density nodes — will look prescient within a relatively short investment horizon. The thesis that treated healthcare real estate as a passive beneficiary of demographic trends, underwriting assets based solely on age cohort data and market occupancy statistics without considering the operational transformation AI represents, will produce results that look worse than the macro tailwind would suggest they should.
The 6 percent ten-year annualized return that MOB has generated against the NCREIF index’s 4.9 percent was produced largely by the first-order demographic story. The next generation of outperformance in healthcare real estate will be produced by investors who identified the AI inflection point before the transaction market fully priced it — which, based on current cap rate compression and the early stage of asset-level bifurcation, remains an available window.
What Investors Need to Be Asking Now
The transition from demographic-driven underwriting to compound demographic-plus-AI underwriting does not require abandoning any of the analytical framework that has worked for MOB investors over the past decade. It requires adding a layer of operational intelligence about AI readiness and infrastructure that most traditional healthcare CRE underwriting does not currently include.
On the tenant side, the relevant questions are about AI adoption stage. Is the tenant operating ambient scribing? Have they deployed AI-powered scheduling and patient flow optimization? Are they using revenue cycle automation? A medical group that has implemented the tools that improve per-room revenue by up to $34,000 annually is a materially different credit than one running the same clinical operations with 2019-era administrative infrastructure. That operational difference will eventually express itself in financial performance and lease renewal capacity, and it should be priced into underwriting assumptions today.
On the asset side, the relevant questions are about infrastructure and design vintage. Does the building have the sensor infrastructure to support real-time occupancy optimization? What is the mechanical and electrical specification relative to the requirements of AI-ready care delivery? Has the layout been optimized for the clinical workflows of current tenants, or is it a legacy configuration that tenants are working around? The answers to those questions are beginning to differentiate assets in ways that market-level cap rate data cannot capture.
On the market side, the relevant questions remain fundamentally demographic — but they need to be calibrated against supply constraints and the AI adoption curve. Markets where the population aged 65 and older is growing fastest, where new medical office supply is most constrained, and where health system tenants have the highest AI adoption rates represent the convergence zone where the compound effect is most powerful. Identifying those markets and the assets within them that are positioned for AI-assisted utilization — that is the next generation of the MOB investment thesis.
The demographic argument told investors where to look. AI is now telling them what to look for when they get there.
The Next Chapter of Healthcare Real Estate Is Already Being Written
A decade from now, the healthcare commercial real estate market will be legible in two distinct eras. The era of demographic-driven investment, which produced consistent outperformance through occupancy stability and inflation-resistant income, will be recognized as the foundation. The era of AI-augmented investment, currently in its early expression, will be recognized as the inflection point where the asset class added a new dimension of value creation — one tied not to how many patients are arriving but to how efficiently and profitably those patients are served.
The investors who identified that inflection point early — who started asking about tenant AI adoption alongside tenant credit, who started evaluating building infrastructure alongside location and parking ratios, who started underwriting the compound effect of demographics times operational AI rather than treating them as separate conversations — those investors are positioning for returns that the demographic thesis alone cannot fully explain.
The demographic story for healthcare real estate is intact. The aging of America is real, ongoing, and powerful. But demographics are a tailwind that lifts the entire asset class. AI is the differentiator that separates the assets that will capture maximum value from that tailwind and the ones that will merely float in it. That distinction is where the analytical premium lives, and at this stage of market recognition, capturing it still requires doing the work that most participants have not yet done.
That is, characteristically, when the work is most worth doing.
BestCRE exists to map commercial real estate AI honestly — the platforms worth paying for, the ones you can replicate yourself, and the market forces shaping where capital is moving. Coverage spans 20 sectors and is evaluated through the 9AI Framework. If you’re deploying capital, advising clients, or building in CRE, this is the resource built for you.
Frequently Asked Questions
What makes medical office buildings different from other commercial real estate as an investment?
Medical office buildings occupy a distinct position in the CRE landscape because their demand is driven by healthcare utilization rather than economic cycles. Tenants are physicians, health systems, and clinical operators whose patient volume is determined by demographics and health status rather than corporate earnings or consumer sentiment. This produces occupancy stability that other asset classes cannot replicate — MOB national occupancy closed at approximately 93 percent in 2026, among the highest levels recorded in the asset class’s history. Combined with triple-net lease structures that pass operating expenses to tenants, long lease durations typical of healthcare occupiers, and the practical difficulty of relocating a clinical practice, MOBs have historically produced income with a durability profile closer to infrastructure than to traditional office. Ten-year annualized returns of 6 percent against the NCREIF index’s 4.9 percent reflect that durability premium.
How is AI actually changing the economics of healthcare real estate right now?
AI is operating through several mechanisms simultaneously. On the revenue side, AI-driven exam room utilization optimization is increasing throughput by up to 20 percent in early-adopting facilities, and research places annual revenue improvement at up to $34,000 per exam room in AI-assisted practices. On the cost side, ambient scribing tools are reducing physician administrative time, revenue cycle automation is improving collection rates and reducing denial-driven write-offs, and predictive scheduling is reducing no-shows and optimizing patient flow. McKinsey’s analysis puts NOI improvement from AI implementation across real estate sectors at greater than 10 percent. For real estate investors, these operational improvements translate to stronger tenant financial performance, improved lease renewal capacity, and lower credit risk in AI-adopting tenants — all of which have underwriting implications that most healthcare CRE analysis does not currently capture.
What is the outpatient migration and why does it matter for MOB investors?
The outpatient migration is the ongoing structural shift of clinical care from inpatient hospital settings to ambulatory outpatient facilities, including medical office buildings, ambulatory surgery centers, and multi-specialty clinics. Outpatient revenue has grown 45 percent since 2020, compared to 16 percent for inpatient, and projections point to an additional 10.6 percent growth over the next five years. Complex procedures that were definitionally hospital-based a decade ago — spinal surgery, cardiac catheterization, certain oncology procedures — are increasingly being performed in ambulatory settings, driven by lower costs, comparable outcomes, and patient preference. The policy environment, including recent Medicaid restructuring that increases cost pressure on providers, is accelerating this shift. For MOB investors, the outpatient migration means that health system anchor tenants are actively expanding their ambulatory real estate footprints, creating demand for well-located, purpose-built outpatient space that the constrained construction pipeline cannot currently satisfy.
What does “AI-ready” mean in practical terms for a medical office building?
An AI-ready medical office building is one whose physical infrastructure supports the operational requirements of AI-assisted care delivery. In practical terms, this means building-wide sensor networks capable of supporting real-time occupancy and utilization monitoring; mechanical and electrical systems that can be managed by smart building AI platforms optimizing HVAC, lighting, and energy based on occupancy data; data connectivity specifications that support the bandwidth requirements of ambient scribing tools, real-time asset tracking, and electronic health record systems; and floor plan configurations that reflect AI-modeled workflows rather than legacy clinical conventions. The distinction from legacy medical office stock is not always visible in a site visit — it shows up in utilization data, in the tenant improvement costs required to bring the building to current clinical operational standards, and in the willingness of the most sophisticated health system tenants to pay premium rents for the capability.
How should the Welltower-Remedy $7.2 billion transaction be interpreted?
The Welltower disposition of 296 assets across 34 states — approximately 18 million square feet of outpatient medical facilities — to Remedy Medical Properties and Kayne Anderson Real Estate at a combined value of approximately $7.2 billion represents the largest healthcare real estate transaction in the asset class’s history. Its interpretive significance is layered. Welltower’s decision to sell reflects a strategic reallocation of capital toward senior housing and high-acuity care settings where demographic acceleration is most intense. The buyers’ decision to acquire at that scale and at compressed cap rates reflects conviction that institutional-quality outpatient medical real estate at scale offers durable income and rent growth characteristics that justify the basis. Both positions are rational, and the fact that sophisticated capital existed on both sides of the transaction simultaneously is evidence of a market beginning to bifurcate around different investment theses within the same asset class. The transaction also signals that portfolio-scale healthcare real estate is liquid at the institutional level — a characteristic that supports the broader market’s credibility as an asset class.
Can individual investors or family offices access healthcare real estate?
Yes, though the access paths differ meaningfully from institutional routes. Direct ownership of a medical office building or ambulatory surgery center is possible for accredited investors and family offices with sufficient capital, but it requires operational expertise, market relationships, and asset management capability that most non-institutional investors do not have independently. The more practical path for most non-institutional capital is through private equity fund structures that pool investor capital alongside institutional limited partners, providing access to institutional-quality deal flow, diversification across markets and asset types, and professional management of the investment. The risk-return profile, hold period expectations, and minimum investment thresholds vary across fund platforms. As with any private real estate investment, the quality of the operator and the specific asset strategy matter more than any headline market condition in determining outcomes.
← Best CRE Office Market: Bifurcation, Not Recovery
← Best CRE Industrial Real Estate: The Electrical Spec Premium
Best CRE Sectors: The 20 Categories of Commercial Real Estate AI in 2026 →